Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Training courses on the prevention of antimicrobial resistance
  • Search

Search

Filter by
  • Filter by
  • Remove this filter Public health area: Antiviral
  • Infectious disease
    • Vaccine preventable diseases (23)
    • Influenza (23)
    • Respiratory diseases (23)
    • Influenza in humans, seasonal (12)
    • Seasonal influenza (12)
    • Flu (12)
    • Influenza A (H1N1)2009 (5)
    • Influenza A (H1N1) (5)
    • Sexually transmitted infections (3)
    • Influenza in humans, pandemic (3)
    • Acquired immunodeficiency syndrome (AIDS) (2)
    • Zoonotic influenza (2)
    • HIV infection (2)
    • Human immunodeficiency virus infection (2)
    • Avian influenza virus (2)
    • Zoonosis (2)
    • Viral hepatitis (1)
    • Hepatitis C (1)
    • Influenza in humans, swine origin (1)
    • Influenza in humans, avian origin (1)
    • Avian influenza in humans (1)
    • Influenza A (H9N2) (1)
  • Public health area
    • Antiviral (27)
    • Prevention and control (27)
    • Disease prevention (10)
    • Prophylaxis (10)
    • Immunisation (8)
    • Vaccination (8)
    • Active immunisation (8)
    • Surveillance (4)
    • Epidemiology (3)
    • Public health response (3)
    • Vaccination coverage (3)
    • Control campaign (3)
    • Microbiology (2)
    • Epidemic (2)
    • Scientific advice (2)
    • Antimicrobial resistance (2)
    • Antibiotic resistance (2)
    • Molecular typing (1)
    • Pandemic preparedness (1)
    • Preventive measure (1)
    • Public health threat (1)
    • Reference laboratory (1)
    • Vaccine efficacy (1)
    • Laboratories (1)
    • Outbreak (1)
    • Threats and outbreaks (1)
    • Vaccine effectiveness (1)
    • HIV testing (1)
  • Country
    • Europe (16)
  • Media type
    • Publication (14)
    • Peer-reviewed publication (10)
    • News (8)
    • ECDC comment (5)
    • Technical report (2)
    • Data (2)
    • Expert opinion (1)
    • Press release (1)
    • Infographic (1)
    • Table (1)
    • Factsheet (1)
    • News story (1)
  • Page 1 of 3 // 27 Results found
    • Sort by:

Publication

Seasonal influenza vaccination and antiviral use in EU/EEA Member States

Technical report - 18 Dec 2018

Overview of vaccine recommendations for 2017–2018 and vaccination coverage rates for 2015–2016 and 2016–2017 influenza seasons.

Seasonal influenza vaccination and antiviral use in EU/EEA Member States - EN - [PDF-1.84 MB]
  • Antiviral
  • EU/EEA
  • Immunisation
  • Influenza
  • Influenza in humans, seasonal
  • Vaccination coverage

News

Influenza vaccination coverage rates insufficient across EU Member States

News story - 18 Dec 2018

None of the European Union (EU) Member States could demonstrate that they reach the EU target of 75% influenza vaccination coverage for vulnerable groups, according to a new report from the European Centre for Disease Prevention and Control (ECDC).

  • Antiviral
  • EU/EEA
  • Immunisation
  • Influenza
  • Influenza in humans, seasonal
  • Vaccination coverage

Peer-Reviewed Publication

A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA

Sep 2018 - J Viral Hepat - 25(12):1406-1422

Vroling, H., Oordt-Speets, A.M., Madeddu, G., Babudieri, S., Monarca, R., O'Moore, E., Vonk Noordegraaf-Schouten, M., Wolff, H., Montanari, M., Hedrich, D., Tavoschi, L.

  • Antiviral
  • EU/EEA
  • Hepatitis C

Data

Table of contributions for the expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza

Table - 14 Aug 2017

The 'Table of contributions' contains all comments received through a public consultation on this topic and lists ECDC’s responses to those comments.

  • Antiviral
  • Europe
  • Influenza
  • Prevention and control

Publication

Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses

Expert opinion - 14 Aug 2017

This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.

Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - EN - [PDF-1.15 MB]
  • Antiviral
  • Avian influenza virus
  • Europe
  • Influenza
  • Influenza in humans, avian origin
  • Influenza in humans, seasonal
  • Prevention and control
  • Scientific advice
  • Zoonotic influenza

News

Expert panel reviews neuraminidase inhibitors for the prevention and treatment of influenza

News - 14 Aug 2017

An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.

  • Antiviral
  • Europe
  • Influenza
  • Prevention and control
  • Scientific advice

Publication

Seasonal influenza vaccination in Europe – Vaccination recommendations and coverage rates for 2013-14 and 2014-15

Technical report - 15 Jul 2016

Overview of vaccination recommendations and coverage rates in the EU Member States for the 2013–14 and 2014–15 influenza seasons.

Seasonal influenza vaccination and antiviral use in Europe - EN - [PDF-1.29 MB]
  • Antiviral
  • EU/EEA
  • Europe
  • Immunisation
  • Influenza
  • Influenza in humans, seasonal
  • Vaccination coverage
  • Vaccine effectiveness
  • Vaccine efficacy

News

Recommendations on antivirals in European countries are appropriate, but remain underutilised in practice

News, Press release - 16 Feb 2016

​Current recommendations in EU countries to use neuraminidase inhibitors (antivirals) for patients with severe influenza are supported by the available evidence, concludes a new expert opinion report from ECDC which is now open for public consultation.

  • Antiviral
  • EU/EEA

Peer-Reviewed Publication

ECDC expert opinion on efficacy and effectiveness of neuraminidase inhibitors published for public consultation

Feb 2016 - Influenza Other Respir Viruses - 10(3):152-153

Penttinen, P., Catchpole, M.

  • Antiviral
  • Influenza
  • Public health threat

News

New and updated evaluations of neuraminidase inhibitors for preventing and treating influenza published

ECDC comment - 2 Jun 2014

This evaluated patients admitted to hospital with laboratory-confirmed or clinically diagnosed influenza A H1N1pdm09 virus infection.

  • Antiviral
  • Immunisation
  • Influenza in humans, seasonal
  • Prevention and control

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us
  • Training courses on the prevention of antimicrobial resistance